131I‐MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta‐analysis

@article{Hulsteijn2014131IMIBGTF,
  title={131I‐MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta‐analysis},
  author={L. T. Hulsteijn and N. D. Niemeijer and O. Dekkers and E. Corssmit},
  journal={Clinical Endocrinology},
  year={2014},
  volume={80}
}
  • L. T. Hulsteijn, N. D. Niemeijer, +1 author E. Corssmit
  • Published 2014
  • Medicine
  • Clinical Endocrinology
  • 131I‐MIBG therapy can be used for palliative treatment of malignant paraganglioma and phaeochromocytoma. The main objective of this study was to perform a systematic review and meta‐analysis assessing the effect of 131I‐MIBG therapy on tumour volume in patients with malignant paraganglioma/phaeochromocytoma. 
    77 Citations
    Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre.
    • 16
    • PDF
    Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.
    • L. Fishbein
    • Medicine
    • Hematology/oncology clinics of North America
    • 2016
    • 63
    • Highly Influenced

    References

    SHOWING 1-10 OF 66 REFERENCES
    Treatment of malignant pheochromocytoma with a new radiopharmaceutical.
    • 42
    Treatment of malignant pheochromocytoma.
    • 89
    Management of malignant phaeochromocytoma: a retrospective review of the use of MIBG and chemotherapy in the West Midlands.
    • 37
    Malignant Pheochromocytomas and Paragangliomas
    • 99
    Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
    • 21
    Treatment of neuroendocrine tumours in adults with 131I-MIBG therapy.
    • J. Bomanji, W. Wong, +4 authors P. Ell
    • Medicine
    • Clinical oncology (Royal College of Radiologists (Great Britain))
    • 2003
    • 49